Bridging the gap between academic IP and technology commercialization.


KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.

Latest News

07.17.20 - Novomer to Probe Functional Beta-Lactones to Enhance Virus Deactivation...more

05.28.20 - Multiple Myeloma DREAM Challenge Reveals Epigenetic Regulator PHF19 as Marker of Aggressive Disease...more

01.07.20 - GNS Healthcare announces strategic investment from Merck Global Health Investment Fund...more

12.04.19 - GNS Healthcare study of Wisconsin healthcare system offers insights on primary care costs and patient benefits...more

11.25.19 - FDA selects NovaSterilis, Steris, Stryker and Noxilizer for challenge grant to offer alternative to ethylene oxide...more


KensaGroup, LLC

2415 N. Triphammer Road

Ithaca, NY 14850

phone: 1.607.330.2307

Fax: 1.607.257.1139